Kanvista Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 M
as on 19-12-2024
- Revenue 41.77%
(FY 2020)
- Profit 16.92%
(FY 2020)
- Ebitda 68.12%
(FY 2020)
- Net Worth 23.87%
(FY 2020)
- Total Assets 39.26%
(FY 2020)
About Kanvista Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Milind Mehta and Deepesh Mehta serve as directors at the Company.
- CIN/LLPIN
U74120MH2013PTC244216
- Company No.
244216
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kanvista Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milind Mehta  | Director | 10-Jun-2013 | Current |
| Deepesh Mehta | Director | 10-Jun-2013 | Current |
Financial Performance of Kanvista Pharma.
Kanvista Drugs Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 41.77% increase. The company also saw a substantial improvement in profitability, with a 16.92% increase in profit. The company's net worth Soared by an impressive increase of 23.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kanvista Pharma?
In 2020, Kanvista Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kanvista Retail India Private LimitedActive 8 years 6 monthsMilind Mehta and Deepesh Mehta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 May 2019 | ₹1.50 M | Open |
How Many Employees Work at Kanvista Pharma?
Unlock and access historical data on people associated with Kanvista Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanvista Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanvista Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
